Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells

Proneural-to-mesenchymal transition (PMT) is a common process in glioblastoma (GBM) progression that leads to increased radiotherapy resistance. However, the mechanism underlying PMT is poorly understood. Here, we found that tumor-associated macrophages triggered PMT in glioma stem cells (GSC) via s...

Full description

Saved in:
Bibliographic Details
Published inCancer immunology research Vol. 8; no. 7; p. 966
Main Authors Zhang, Zongpu, Xu, Jianye, Chen, Zihang, Wang, Huizhi, Xue, Hao, Yang, Chunlei, Guo, Qindong, Qi, Yanhua, Guo, Xiaofan, Qian, Mingyu, Wang, Shaobo, Qiu, Wei, Gao, Xiao, Zhao, Rongrong, Guo, Xing, Li, Gang
Format Journal Article
LanguageEnglish
Published United States 01.07.2020
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Proneural-to-mesenchymal transition (PMT) is a common process in glioblastoma (GBM) progression that leads to increased radiotherapy resistance. However, the mechanism underlying PMT is poorly understood. Here, we found that tumor-associated macrophages triggered PMT in glioma stem cells (GSC) via small extracellular vesicles (sEV). sEVs from monocyte-derived macrophages transferred , and to GSCs, and these miRNAs promoted several mesenchymal phenotypes in proneural (PN) GSCs by simultaneously targeting We found that CHD7 played a critical role in the maintenance of the PN phenotype, and knockdown significantly promoted PMT in GSCs via the RelB/P50 and p-STAT3 pathways. The induction of PMT by sEVs containing , and in a xenograft nude mouse model exacerbated radiotherapy resistance and thus decreased the benefits of radiotherapy. Collectively, these findings identified macrophage-derived sEVs as key regulators of PMT in GSCs and demonstrated that CHD7 is a novel inhibitor of PMT.
ISSN:2326-6074
DOI:10.1158/2326-6066.cir-19-0759